KARYOPHARM THERAPEUTICS INC (KPTI)       5.46  +0.09 (+1.68%)

5.46  +0.09 (+1.68%)

US48576U1060 - Common Stock - After market: 5.4 -0.06 (-1.1%)

Buy % Consensus

77
Analysts have set a mean price target of 9.75. This target is 78.51% above the current price.
KPTI was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about KPTI.
In the previous month the buy percentage consensus was at a similar level.
KPTI was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 5.465.057.149.7518.90 - -7.51% 30.77% 78.51% 246.15%

Up and Down Grades

Date Firm Action Rating
2022-09-09 Morgan Stanley Maintains Equal-Weight
2022-08-05 Barclays Maintains Overweight
2022-08-05 Baird Maintains Outperform
2022-08-05 HC Wainwright & Co. Maintains Buy
2022-05-05 SVB Leerink Maintains Market Perform
2022-03-08 RBC Capital Maintains Sector Perform
2022-03-02 SVB Leerink Maintains Market Perform
2022-02-09 JP Morgan Upgrade Underweight -> Neutral
2022-01-10 SVB Leerink Maintains Market Perform
2021-12-09 RBC Capital Maintains Sector Perform
2021-11-19 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-10-12 Morgan Stanley Maintains Overweight
2021-08-06 RBC Capital Downgrade Outperform -> Sector Perform
2021-08-06 SVB Leerink Downgrade Outperform -> Market Perform
2021-08-06 JP Morgan Downgrade Overweight -> Underweight
2021-08-06 HC Wainwright & Co. Maintains Buy
2021-05-03 SVB Leerink Maintains Outperform
2021-02-11 SVB Leerink Maintains Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA